Prevention of Early Postoperative Decline (PEaPoD)
Delirium, Postoperative Cognitive Dysfunction
About this trial
This is an interventional prevention trial for Delirium focused on measuring Cardiac Surgery, Delirium, Postoperative Cognitive Dysfunction
Eligibility Criteria
Inclusion Criteria:
- Adult patients undergoing cardiac surgery age 60-90
- Cardiac surgery scheduled at least 10 days from enrollment
- High school education level or equivalent
Exclusion Criteria:
- Preexisting psychiatric illness
- History of cerebrovascular event or seizure
- Non English speakers
- Baseline severe cognitive dysfunction including Alzheimer's, Parkinson's, or other severe forms of dementia
- Significant visual impairment
- Enrollment in another study involving cognition
Sites / Locations
- Beth Israel Deaconess Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Lumosity (CT Group)
Usual Care (Control Group)
Patients in the Lumosity arm will be prescribed a perioperative neurocognitive training program created in collaboration with Lumos Labs, Inc. The program will contain "brain games" that focus on enhancing cognitive abilities in working memory, attention, and processing speed. Participants will be expected to complete at least 2, but no more than 3, 15 minute sessions of training per day. The protocol will be prescribed for 10 days preoperatively, and then for four weeks postoperatively.
Patients in the usual care arm will undergo current standard of care for cardiac surgery and postoperative recovery. They will be asked to refrain from acquiring a Lumosity account.